New antibody treatment tested for serious liver virus
Disease control
Completed
This study tested an experimental antibody treatment called HH-003 in adults with chronic hepatitis delta virus infection, a serious liver disease. The goal was to see if the treatment could safely reduce the amount of virus in the blood and improve liver health. It was a mid-sta…
Phase: PHASE2 • Sponsor: Huahui Health • Aim: Disease control
Last updated Mar 30, 2026 14:31 UTC